Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 77 Next >>

Filter Applied: drug induced neurologic disorders (Click to remove)

Retinitis Pigmentosa
Surv Ophthalmol 33:137-177, Pagon,R.A., 1988

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

Progressive Cervical Osteophytosis and Dysphagia Associated with Isotretinoin Treatment for Rosacea
Lancet 404:e4, Naraghi,K. & Marzo-Ortega,H., 2024

Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023

Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted Diffusion (CHANTER) Syndrome
Neurocrit Care 31:228-296, Jasne, A.S.,et al, 2019

"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
NEJM 376-235-242, Adams, A.J.,et al, 2017

A Case of Altered Mental Status, Not Otherwise Specified
Neurol 89:e154-e158, Swor, D.E.,et al, 2017

Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016

Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015

Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012

Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011

Fast-In, Fast-Out
Lancet 373:1398, Hefele,B.,et al, 2009

Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
Arch Neurol 66:865-869, Orr,C.F. &Ahlskog,E., 2009

Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006

The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005

Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003

Clinicopath Conf, Strychnine Poisoning, Case 12-2001
NEJM 344:1232-1239, , 2001

Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000

Treatment of Drug-Induced Psychosis with Quetiapine and Clozapine in Parkinson's Disease
Neurol 55:1753-1754, Dewey,R.B.Jr. & O'Suilleabhain,P.E., 2000

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998

Non-Barbiturate, Drug-Induced Reversible Loss of Brainstem Reflexes
Neurol 51:639-640, Richard,I.H.,et al, 1998

Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998

Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998

Trimethoprim and Sulfonamide-Associated Meningoencephalitis with MRI Correlates
Neurol 46:556-558, Blumenfeld,H.,et al, 1996

Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996

Opsoclonus
Semin Neurol 16:21-26, Averbuch-Heller,L.&Remler,B., 1996

Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996

Serotonin Syndrome
Neurol 45:219-223, Bodner,R.A.,et al, 1995

Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995

Neurotoxicity in Liver Transplant Recipients with Cyclosporine Immunosuppression
Neurol 45:1962-1964, Wijdicks,E.F.M.,et al, 1995

Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995

Neurologic Manifestations of Cocaine Exposure in Childhood
Pediatrics 93:557-560, Mott,S.H.,et al, 1994

Neuropathologic Correlated of Persistent Neurologic Deficit in Lithium Intoxication
Ann Neurol 36:928-931, Schneider,J.A.&Mirra,S.S., 1994

Acyclovir-Induced Neurotoxicity:Concentration-Side Effect Relationship in Acyclovir Overdose
Am J Med 94:212-215, Haefeli,W.E.,et al, 1993

Acute Psychosis Associated with Oral Trimethoprimsulfamethoxazole Therapy
Can J Psych 38:56-58, Gregor,J.C.,et al, 1993

Ranitidine Pharmacokinetics and Adverse Central Nervous System Reactions
Arch Int Med 152:2325-2329, Slugg,P.H.,et al, 1992

Drug Induced Creutzfeldt-Jakob Like Syndrome
J Psychiatr Neurosci 17:103-105, Finelli,P.F., 1992

Evaluation and Management of the Patient with Syncope
JAMA 268:2553-2560, Kapoor,W.N., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992

Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991

Akinetic Mutism after Baclofen
Ann Int Med 115:499-500, Parmar,M.S., 1991

Acute Psychoses Associated with the Use of Ciprofloxacin & Trimethoprim-Sulfamethoxazole
Am J Med 90:528-529, McCue,J.D.&Zandt,J.R., 1991

CNS Side Effects of Nonsteroidal Anti-Inflammatory Drugs, Aseptic Meningitis, Psychosis & Cognitive Dysf
Arch Int Med 151:1309-1313, Hoppmann,R.A.,et al, 1991

A Wernicke's Encephalopathy-Like Neurotoxicity Induced by Erbulozole
Neurol 41:762-763, DeKloppel,N.,et al, 1991

Cyclosporine-Related Central Nervous System Toxicity in Cardiac Transplantation
NEJM 323:420-421, Hughes,R.L., 1990

Nontraumatic Coma, Glasgow Coma Score and Coma Etiology as Predictors of 2-Week Outcome
Arch Neurol 47:1181-11884, Sacco,R.L.,et al, 1990



Showing articles 0 to 50 of 77 Next >>